Will COVID-19 change attitudes to telehealth?
REPORT
13 May 2020
Will COVID-19 change attitudes to telehealth?

Before the coronavirus pandemic, both health providers and patients were reluctant to embrace telehealth, despite the convenience. But attitudes are changing as people see the benefits of going remote. What can brands do to provide the quality of care people expect, but from a distance?

Dr. Joseph Kvedar

Dr. Joseph Kvedar is a professor of dermatology at Harvard Medical School and the president of the American Telemedicine Association. He is also the editor in chief of npj Digital Medicine, a Nature research journal, and author of The Internet of Healthy Things and The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan.

Dr. David Ficker

Dr. David Ficker is a neurologist with the Epilepsy Center at the University of Cincinnati Gardner Neuroscience Institute, an associate professor of neurology at the University of Cincinnati, and chair of the Epilepsy Foundation’s Professional Advisory Board.

Chiara Longoni

Dr. Chiari Longoni is a behavioural scientist and assistant professor of marketing at Boston University’s Questrom School of Business. Her research explores the social impact of artificial intelligence and technology, sustainability, and consumer and societal welfare. She also specialises in issues related to medical decision-making, sustainability in consumer and firm behaviour, and messaging to promote consumer and societal wellbeing.

Heather Tirado Gilligan

Heather Tirado Gilligan is a journalist based in Oakland. She covers health and health policy and her writing has appeared in publications including Slate, The Nation, and The Huffington Post. Follow her on Twitter @heathergilligan.